Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 32 Clinics in the ThedaCare health system


The results below represent the care of 3,902 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
THEDACARE BEHAVIORAL HEALTH - MIDWAY

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NEW LONDON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NORTH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - OSHKOSH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - SHAWANO

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - TCA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - WAUPACA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS - ENDOCRINOLOGY NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS BLACK CREEK

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS CLINTONVILLE
N=130
96.15 %
View Historical Data
THEDACARE PHYSICIANS DARBOY
N=152
96.05 %
View Historical Data
THEDACARE PHYSICIANS HILBERT

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS INTERNAL MEDICINE - KNAUS

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS INTERNAL MEDICINE APPLETON
N=397
95.21 %
View Historical Data
THEDACARE PHYSICIANS INTERNAL MEDICINE NEENAH
N=222
97.30 %
View Historical Data
THEDACARE PHYSICIANS IOLA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS KIMBERLY
N=168
97.02 %
View Historical Data
THEDACARE PHYSICIANS MANAWA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS MENASHA
N=258
98.84 %
View Historical Data
THEDACARE PHYSICIANS NEENAH
N=393
96.44 %
THEDACARE PHYSICIANS NEW LONDON
N=414
96.62 %
View Historical Data
THEDACARE PHYSICIANS NORTH
N=450
98.22 %
View Historical Data
THEDACARE PHYSICIANS OSHKOSH
N=156
97.44 %
View Historical Data
THEDACARE PHYSICIANS PEDIATRICS APPLETON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS PEDIATRICS NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS SENIOR CARE SPECIALISTS

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS SHAWANO
N=497
96.98 %
View Historical Data
THEDACARE PHYSICIANS TIGERTON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS WAUPACA
N=493
98.38 %
View Historical Data
THEDACARE PHYSICIANS WEST
N=172
99.42 %
View Historical Data
THEDACARE PHYSICIANS WEYAUWEGA

The number of patients or providers is too small for
purposes of reliably reporting performance

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.

Based on trials involving other secondary prevention therapies, the ACC and AHA recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions.

This measure shows the percentage of people 18 to 75 years of age with a diagnosis coronary or other atherosclerotic vascular disease who were prescribed oral antiplatelet therapy, unless contraindicated, in the measurement year.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.